Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells

Abstract

The correction of genetic mutations by homologous recombination is an attractive approach to gene therapy. We used the DNA double-strand breaks introduced by the site-specific endonuclease I-Sce1 as a means of increasing homologous recombination of an exogenous DNA template in murine hematopoietic stem cells (mHSCs). To develop this approach, we chose an Artemis knockout (Art−/−) mouse in which exon 12 of the Artemis gene had been replaced by an I-Sce1 recognition site. The I-Sce1 enzyme and the Artemis correction template were each delivered by a self-inactivating (SIN)-integrase-defective lentiviral vector (SIN-IDLV-CMV-ISce1 and SIN-IDLV-Art, respectively). Transduction of Art−/− mHSCs with the two vectors successfully reverted the Art−/− phenotype in 2 of our 10 experiments. Even though the potential for genotoxicity has yet to be evaluated, this new approach to gene editing appears to be promising. Improving the efficacy of this approach will require further technical work.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M . 20 years of gene therapy for SCID. Nat Immunol 2010; 11: 457–460.

    Article  CAS  Google Scholar 

  2. Porteus M . Homologous recombination-based gene therapy for the primary immunodeficiencies. Ann N Y Acad Sci 2011; 1246: 131–140.

    Article  CAS  Google Scholar 

  3. Cornu TI, Cathomen T . Targeted genome modifications using integrase-deficient lentiviral vectors. Mol Ther J Am Soc Gene Ther 2007; 15: 2107–2113.

    Article  CAS  Google Scholar 

  4. Tichy ED, Pillai R, Deng L, Liang L, Tischfield J, Schwemberger SJ et al. Mouse embryonic stem cells, but not somatic cells, predominantly use homologous recombination to repair double-strand DNA breaks. Stem Cells Dev 2010; 19: 1699–1711.

    Article  CAS  Google Scholar 

  5. Choulika A, Perrin A, Dujon B, Nicolas JF . Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol Cell Biol 1995; 15: 1968–1973.

    Article  CAS  Google Scholar 

  6. Benjelloun F, Garrigue A, Demerens-de Chappedelaine C, Soulas-Sprauel P, Malassis-Séris M, Stockholm D et al. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells. Mol Ther J Am Soc Gene Ther 2008; 16: 1490–1499.

    Article  CAS  Google Scholar 

  7. Moshous DCI, Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 2001; 105: 177–186.

    Article  CAS  Google Scholar 

  8. Stephan V, Wahn V, Le Deist F, Dirksen U, Broker B, Müller-Fleckenstein I et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med 1996; 335: 1563–1567.

    Article  CAS  Google Scholar 

  9. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD . Genome editing with engineered zinc finger nucleases. Nat Rev Genet 2010; 11: 636–646.

    Article  CAS  Google Scholar 

  10. Urnov FD, Miller JC, Lee Y-L, Beausejour CM, Rock JM, Augustus S et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005; 435: 646–651.

    Article  CAS  Google Scholar 

  11. Lombardo A, Genovese P, Beausejour CM, Colleoni S, Lee Y-L, Kim KA et al. Gene editing in human stem cells using zinc finger nucleasesand integrase-defective lentiviral vector delivery. Nat Biotechnol 2007; 25: 1298–1306.

    Article  CAS  Google Scholar 

  12. Pattanayak V, Ramirez CL, Joung JK, Liu DR . Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods 2011; 8: 765–770.

    Article  CAS  Google Scholar 

  13. Cornu TI, Cathomen T . Quantification of zinc finger nuclease-associated toxicity. Methods Mol Biol Clifton NJ 2010; 649: 237–245.

    Article  CAS  Google Scholar 

  14. Santoni de Sio FR, Cascio P, Zingale A, Gasparini M, Naldini L . Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction. Blood 2006; 107: 4257–4265.

    Article  CAS  Google Scholar 

  15. Paulk NK, Loza LM, Finegold MJ, Grompe M . AAV-mediated gene targeting is significantly enhanced by transient inhibition of nonhomologous end joining or the proteasome in v ivo. Hum Gene Ther 2012; 23: 658–665.

    Article  CAS  Google Scholar 

  16. Gaj T, Gersbach CA, Barbas CF 3rd . ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 2013; 31: 397–405.

    Article  CAS  Google Scholar 

  17. Rivera-Munoz P, Soulas-Sprauel P, Le Guyader G, Abramowski V, Bruneau S, Fischer A et al. Reduced immunoglobulin class switch recombination in the absence of Artemis. Blood 2009; 114: 3601–3609.

    Article  CAS  Google Scholar 

  18. Yáñez-Muñoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, Smith AJ et al. Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 2006; 12: 348–353.

    Article  Google Scholar 

  19. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D . Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871–875.

    Article  CAS  Google Scholar 

  20. Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T . A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 1994; 91: 9564–9568.

    Article  CAS  Google Scholar 

  21. Iglesias MC, Frenkiel M-P, Mollier K, Souque P, Despres P, Charneau P . A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus. J Gene Med 2006; 8: 265–274.

    Article  CAS  Google Scholar 

  22. Six EM, Benjelloun F, Garrigue A, Bonhomme D, Morillon E, Rouiller J et al. Cytokines and culture medium have a major impact on human in vitro T-cell differentiation. Blood Cells Mol Dis 2011; 47: 72–78.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was part of the INGENIS project, which is funded by the French government (via the Direction Générale de la Compétitivité, de l’Industrie et des Services) and the Medicen cluster.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Rivière.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rivière, J., Hauer, J., Poirot, L. et al. Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells. Gene Ther 21, 529–532 (2014). https://doi.org/10.1038/gt.2014.20

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2014.20

This article is cited by

Search

Quick links